STERIS plc Stock
STERIS plc Stock
STERIS plc is currently one of the favorites of our community with 8 Buy predictions and no Sell predictions.
Pros and Cons of STERIS plc in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of STERIS plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| STERIS plc | - | - | - | - | - | - | - |
| Smith & Nephew plc | -0.650% | 2.648% | 7.401% | 24.068% | 7.703% | 15.547% | -16.339% |
| Dexcom Inc. | 0.460% | 0.408% | -1.384% | -30.329% | 3.158% | -46.187% | -29.133% |
| Dentsply Sirona Inc. | 0.410% | -4.828% | 3.844% | -37.360% | 14.077% | -68.026% | -75.561% |
Comments
STERIS (NYSE:STE) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for STE provided by MarketBeat
STERIS (NYSE:STE) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for STE provided by MarketBeat
STERIS plc (NYSE: STE) had its price target raised by analysts at Morgan Stanley from $276.00 to $295.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for STE provided by MarketBeat